HEALTH FOR ALL
through digital health
G4A provides digital health startups with the skills and expertise to bring ideas to life by helping with the most difficult parts of being a young company. Through our digital health partnerships, we have key resources and support from Bayer that can help lead to successful health solutions.
As Europe’s first accelerator by a pharmaceutical company, Bayer has supported over 150 digital health companies, resulting in more than 30 direct collaborations.
Startups since 2014
Total Alumni Value
Designed for mature companies with a product or a solution that has already entered the market. The advance track provides commercial partnership opportunities with Bayer.
Designed for companies in the early-mid stage of their journey. The selected startups receive funding, executive mentorship and coaching.
We seek VC’s and other investors to co-invest in high growth digital health startups.
What our alumni have to say
Dr. Tryggvi Thorngeirsson
“Bayer has always been at the forefront of innovation in disease prevention and management, so we were thrilled to be invited to G4A. There is a tremendous opportunity to empower people to reduce their risk of lifestyle related diseases, and it’s exciting to explore how we can deliver elective tools to help realize that opportunity on a global scale.”
CEO & Co-Founder
“The G4A program was a transformative experience for Turbine. It was a fantastic opportunity to validate our platform at an early stage… since then, our partnership with Bayer evolved into several exciting collaborations with the promise of breaking new grounds in cancer therapies.”
“The G4A ecosystem is one of the most important assets in the industry around the world… we have learned a lot of valuable insights and knowledge about the digital health business… We were able to grow our early stage startup into a true healthcare company with partnerships, guidance and financial support from G4A.”